Telehealth Extension Announced DEA & Ryan Haight Act Update
Due to the overwhelming number of comments the DEA received related to requiring the in-person assessment, we have received word the DEA is going to extend the Telehealth Covid Provisions until further notice.
This means you WILL NOT BE REQUIRED to complete in-person visits for controlled substance appointments until the DEA makes a final decision.
Thank you to everyone who made formal comments on this issue.
"Statement from the DEA Administrator Anne Milgram on COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
May 03, 2023
DEA Administrator
The Drug Enforcement Administration received a record 38,000 comments on its proposed telemedicine rules. We take those comments seriously and are considering them carefully. We recognize the importance of telemedicine in providing Americans with access to needed medications, and we have decided to extend the current flexibilities while we work to find a way forward to give Americans that access with appropriate safeguards. For this reason, last week, DEA, in concert with the Department of Health and Human Services, submitted a draft Temporary Rule to the Office of Management and Budget entitled “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” Further details about the rule will become public after its full publication in the Federal Register."
The link to the DEA press release is available HERE DNP Consulting will be sure to keep you all up to date as soon as we know more. Sincerely, Dr. Renee Pennington, PMHNP, DNP President DNP Consulting, LLC